Search
for
Sort by
Research 781–810 of 1000+
- Increased serum interleukin-17A levels correlate with disease severity and poor prognostic factors in patients with alopecia areata
- 314 Molecular genetic dissection of ILVEN leads to successful targeted therapy
- Skin Diseases (Noncancerous)
- Quality of life assessment in males with androgenetic alopecia – a prospective study
- Non-scarring Alopecia in Pemphigus Foliaceus
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- Race and Ethnicity Sub-Groups of Alopecia Areata Patients have Differing Clinical Characteristics: TARGET-DERM AA
- Skin ‑ a vast organ with immunological function (Review)
- Nutritional Clinical Studies in Dermatology
- The Role of the Gut Microbiome and Microbial Dysbiosis in Common Skin Diseases
- Janus Kinase inhibitors in dermatology: a review
- Subject Index
- Mechanisms of autophagy and their implications in dermatological disorders
- Pharmacological Treatment of Alopecia
- The Role of Janus Kinase Inhibitors in Dermatology
- A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment
- Skin and hair disorders
- The spectrum of nephrocutaneous diseases and associations
- Prevalence of Dermatologic Side Effects of Mood Stabilizers in Bipolar Disorder: A Systematic Review and A Meta-Analysis
- Genomewide Scan for Linkage Reveals Evidence of Several Susceptibility Loci for Alopecia Areata
- Acne-associated syndromes: models for better understanding of acne pathogenesis
- A keratin scaffold regulates epidermal barrier formation, mitochondrial lipid composition, and activity
- Dermatoses of Pregnancy - Clues to Diagnosis, Fetal Risk and Therapy
- Toxic Epidermal Necrolysis
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- JAK Inhibitors for Treatment of Alopecia Areata
- Imbalance of T‐helper 17 and regulatory T cells in patients with alopecia areata
- Prevalence, comorbidities, and treatment patterns of Japanese patients with alopecia areata: A descriptive study using Japan medical data center claims database
- Scalp Dermatoscopic Findings in Androgenetic Alopecia and Their Relations with Disease Severity